Adaptive Biotechnologies Corporation (ADPT) Stock Overview
NASDAQ · Healthcare · Diagnostics & Research
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to…
Source: Yahoo Finance
Sector & Industry
Adaptive Biotechnologies Corporation operates in the Healthcare sector, within the Diagnostics & Research industry group. It is listed on the NASDAQ exchange.
Adaptive Biotechnologies Corporation at a Glance
| Company | Adaptive Biotechnologies Corporation |
| Ticker | ADPT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $24.28 |
| Market cap | $3.87B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.40 |
| 52-week high | $26.87 |
| 52-week low | $12.00 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 2.10 |
| Return on equity (ROE) | -38.76% |
| Debt-to-equity | 272.46% |
| Average volume | 2.89M |
| Shares outstanding | 159.60M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 624 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Adaptive Biotechnologies Corporation's current P/E ratio?
- Adaptive Biotechnologies Corporation (ADPT) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Adaptive Biotechnologies Corporation's market capitalisation?
- Adaptive Biotechnologies Corporation's market cap is $3.87B based on our latest snapshot. See how it ranks by market cap →
- What is ADPT's 52-week range?
- Over the past 52 weeks, ADPT has traded between $12.00 and $26.87. What does the 52-week range mean? →
- How volatile is Adaptive Biotechnologies Corporation compared to the market?
- Adaptive Biotechnologies Corporation has a beta of 2.10, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Adaptive Biotechnologies Corporation pay a dividend?
- Adaptive Biotechnologies Corporation does not currently pay a dividend according to our latest data.
- What exchange is ADPT listed on?
- ADPT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Adaptive Biotechnologies Corporation in?
- Adaptive Biotechnologies Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →